NLS Pharmaceutics

/NLS Pharmaceutics

IPO

NLS Pharmaceutics

Pharmaceutical

We are an innovative biotechnology company engaged in the discovery and development of life-improving drug therapies to treat rare and complex central nervous system, or CNS, disorders, including narcolepsy, idiopathic hypersomnia, or IH, and other rare sleep disorders, as well as neurodevelopmental disorders, such as Attention Deficit Hyperactivity Disorder, or ADHD. Pharmaceutics Ltd. is offering units, or Units, each consisting of one of our common shares and one Warrant to purchase one of our common shares, or, each, a Warrant, in an initial public offering.

Symbol

NLSP

Price Range
$5.00 - $6.00

Final Shares
3,636,000

Anticipated Date
December 11, 2020

Underwriters
MAXIM GROUP LLC

This offering is orderable

To view the prospectus for NLS Pharmaceutics IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277